Call for Abstracts
Abstract Submission is Now OPEN
The Abstract Submission portal for cGvHD 2024 is now open. Please click on the button below to submit your abstract.
Abstract Submission Guidelines
Authors are asked to present their work with precise and clear objectives, directly related to their evidence and scientific support to support their research or clinical study. The Executive Committee and the Scientific Board of the Congress will evaluate each abstract presented.
Instructions for Writing and Submitting Abstracts
We invite fellows/people in training who would like to present an oral/poster presentation to submit an abstract for consideration by the Scientific Committee. Abstracts must be submitted in one of the following categories:
- Chronic GvHD – preclinical/basic research
- Chronic GvHD – clinical research
- Supportive care and quality of life.
Complete abstracts must be submitted online no later than 5PM in your local time zone on the deadline date. The Scientific Committee will determine whether the abstract will be accepted for an oral presentation. Those not accepted for an oral presentation will be considered for a poster. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Congress agency, and of all communications thereafter.
Copyright Statement: Authors of each abstract retain the copyright for their own abstracts.
Formatting Instructions
Language: The abstract must be written in English. Your submission should be edited to ensure clear communication of your work.
- Topic Selection: All abstract submissions must be submitted under one of the categories listed in the guidelines.
- Presentation Format: Please indicate your primary preference regarding abstract presentation format, either oral or as a poster.
- Word Count: Total length of abstract must not exceed 500 words. The submission title is not included in this count.
- Title format: Title must be sentence case with no period at the end
- Authors & Institutions: Please enter all abstract authors in order from subordinate to superior. The presenting author must be listed first. Please be sure to include first and last name. The initials of any middle names can be added. List each organization in full (no abbreviations).
- Sections: Abstracts should include the following sections: Background, Purpose, Methods, Results, and Conclusions.
- Acronyms/Abbreviations: These should be defined the first time they appear. Eg. hematopoietic cell transplantation (HCT).
- Figures: One (1) figure and/or one (1) table is permitted. If included, figure must be of sufficiently high resolution with a concise and editable title and caption underneath. Tables must be fully editable and presented in MS Word format.
- Links: When making reference to a webpage, use the full clickable link and include date accessed or posted.
Frequently Asked Questions
Are case reports considered for abstracts?
No, we do not allow the submission of case reports.
Does cGVHD accept abstracts that have been submitted and presented to a previous Conference (ie, encore abstracts, trials in progress encore abstracts)?
An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the presentation. Submitters are required to list any previous presentations in the introduction section of the abstract.
When will I receive the Notification Letter?
Notification Letters will be sent in early August
I am having trouble submitting my abstract – what can I do?
If you have questions or troubles, please email at cgvhd2024-program@icsevents.com.
Important Dates
March 25, 2024
Early Registration Opens
May 16, 2024
Abstracts Submissions Open
August 5, 2024
Abstract Submission Deadline
August 16, 2024
Abstract Notifications
August 15, 2024
Early Registration Deadline
September 29, 2024
Accommodation Booking Deadline
October 9, 2024
Registration Deadline